1.How to optimize the clinical therapeutic protocol for triple-positive breast cancer.
Chinese Journal of Oncology 2010;32(4):241-243
Antibodies, Monoclonal
;
therapeutic use
;
Antibodies, Monoclonal, Humanized
;
Antineoplastic Agents, Hormonal
;
therapeutic use
;
Breast Neoplasms
;
metabolism
;
pathology
;
therapy
;
Female
;
Humans
;
Lymphatic Metastasis
;
Receptor, ErbB-2
;
metabolism
;
Receptors, Estrogen
;
metabolism
;
Receptors, Progesterone
;
metabolism
;
Signal Transduction
;
Tamoxifen
;
therapeutic use
;
Trastuzumab
2.Association of high-sensitivity C-reactive protein with risk factors of cerebral infarction in patients with type 2 diabetic mellitus
Chinese Journal of Primary Medicine and Pharmacy 2006;0(09):-
Objective To examine the serum high-sensitivity C-reactive protein(hs-CRP)levels in subjects with type 2 diabetic mellitus(DM)or DM accompanied by cerebral infarction(DM+CI),and the relationship be- tween the serum high-sensitivity C-reactive protein(hs-CRP)levels,and to investigate risk factors of cerebral infarc- tion in patients with type 2 diabetic mellitus.Methods The serum high-sensitivity C-reactive protein(hs-CRP)lev- els were measured in 50 DM patients,50 DM+CI patients and 30 healthy controls by ultra-sensitive immunoassay. hs-CRP values and its relationship with cerebral infarction in patients with type 2 diabetic mellitus and other factors, such as age,BMI,TG,etc,were analyzed.Results Univariate analysis revealed significant differences in hs-CRP concentrations between controls[(0.73?0.46)mg/L]and subjects with DM[(2.26?1.38)mg/L],or subjects with DM+CI[(3.82?2.67)mg/L](P
4.Expression of YAP in human papillary thyroid cancer and its influence on cell growth
Chongqing Medicine 2016;45(12):1653-1655
Objective To investigate the expression of Yes‐associated protein(YAP) in human papillary thyroid cancer and its influence on cell growth .Methods The samples in 57 cases of papillary thyroid cancer treated by operation resection in the gen‐eral surgery department of this hospital and the matched tumor‐adjacent tissues were collected .All the cases were definitely diag‐nosed by the pathology examination .The expression of YAP protein in the cancer tissue and corresponding tumor‐adjacent tissue were determined by the immunohistochemistry(IHC)staining .The relationship between the YAP protein and the clinicopathological data was statistically analyzed .siRNA was used to silence the expression of YAP in B‐CPAP cells ,MTT and flow cytometry were used to measure the proliferation and apoptosis changes .Results The expression level of YAP was markedly higher in papillary thyroid cancer tissues than in tumor adjacent tissues (P<0 .05);moreover the expression of YAP protein was positively correlated with the tumor size and TNM stage (P<0 .05) .Silencing YAP gene could significantly inhibit the cell proliferation ability and pro‐mote cell apoptosis(P<0 .05) .Conclusion YAP is highly expressed in papillary thyroid cancer tissues and is related with its ad‐verse clinicopathological characteristics ,down‐regulating YAP gene can significantly inhibit the cell growth .
5.Mechanisms of proteasome inhibitor bortezomib on the therapy of multiple myeloma
Journal of Leukemia & Lymphoma 2011;20(11):698-700
The ubiquitin-proteasome pathway is one of important pathways during selective protein degradation,which participates in many intracellular physiological and biochemical processes.Bortezomib,a kind of proteasome inhibitor,can inhibit cell growth and proliferation,induce cell apoptosis and overcome drug resistance in chemotherapy.The mechanisms of bortezomib on the therapy of multiple myeloma are reviewed in this paper.
6.Study on Ultrasonic Follow-up on Atheriosclerosis in Familial Hypercholesterolemia
qiang, YONG ; zhi-an, LI ; jie, LIN ; lu-ya, WANG
Journal of Applied Clinical Pediatrics 2006;0(13):-
Objective To identify the arteriosclerosis (AS)changes in peripheral artery and abdominal aorta of patients with familial hypercholesterolemia(FH) during follow-up.Methods Seventeen patients of 6 FH [5 male and 12 female with average age of (16.12?6.65) years old],along with 17 subjects of matching sexes and ages with normal blood cholesterol as healthy control group,underwent examination by color doppler ultrasound,and changes of intima-media thickness (IMT) in peripheral artery and abdominal aorta,severity of stenosis,morphology,and function were observed.Results For 17 patients of FH,the total cholesterol(TC),low density lipoprotein cholesterol(LDL-C) in serum were higher significantly and high density lipoprotein cholesterol (HDL-C) was lower significantly than those in healthy control group(Pa0.05).The IMT of carotid aorta,subclavicular aorta,common abdominal artery,and common femoral artery in 13 patients were showing various degrees of increase,yielding an average of 2.9 mm.As patients aged,this phenomenon was reported to be more profound in common abdominal aorta and femoral artery.Conclusions Patients of FH show AS lesion in early stage and it worsened as they aged,from carotid arteries to common abdominal aorta and femoral artery.Color doppler ultrasound can be a non-invasive examination for monitoring the progress of AS in blood vessels in patients of diagnosed FH.
7.Effect of Local Intramuscular Repeated Injection with Botulinum Toxin-A for Treatment of Spastic Cerebral Palsy
ya-jie, WANG ; bao-qin, GAO ; wei-li, YANG
Journal of Applied Clinical Pediatrics 2004;0(08):-
Objective To observe the curative effect of botulinum toxin A(BTX-A)repeated intramuscular injection for treatment of serious spastic cerebral palsy.Methods Thirty cases with serious spastic cerebral palsy received local repeated intramuscular injection. The interval time was 3 months. The dose of BTX-A was 4 U/kg.The muscle tone was assessed with the modified ashworth scale and range of motion with physical rating scale(PRS).The indexes were evaluated before injection and 3 months after the second injection. Paired-samples t-test was used in the statistic analysis.Result The muscle tone and PRS had remarkable improvement after second therapy with BTX-A(P
8.Clinical observation of electroacupuncture with different frequencies for migraine without aura
Jie GONG ; Mi-Mi XU ; Ya-Ying PAN
Journal of Acupuncture and Tuina Science 2021;19(2):129-132
Objective: To observe the clinical efficacy of electroacupuncture (EA) with different frequencies in treating migraine.Methods: Ninety patients with migraine were divided into a low frequency electroacupuncture (LF-EA) group, a high frequency electroacupuncture (HF-EA) group and a variable frequency electroacupuncture (VF-EA) group by the random number table method. Shuaigu (GB 8), Hegu (LI 4), Waiguan (TE 5), Taichong (LR 3), Taiyang (EX-HN 5), Fengchi (GB 20) and Ashi points were selected for all three groups. After achieving needling sensation (Deqi), the LF-EA group received 2 Hz continuous wave EA stimulation; the HF-EA group received 100 Hz continuous wave EA stimulation, and the VF-EA group received 2 Hz/100 Hz sparse-dense wave EA stimulation. The EA stimulation lasted for 30 min in all the three groups, once a day, 10 times as a course, and the clinical efficacy was evaluated after 2 consecutive courses of treatment. Results: After treatment, the total effective rates in the LF-EA group, HF-EA group and VF-EA group were 77.7%, 83.3% and 93.3%, respectively. The difference in total effective rate between the LF-EA and HF-EA groups was not statistically significant (P>0.05), but the total effective rate was significantly higher in the VF-EA group than in the LF-EA and HF-EA groups (both P<0.01). After treatment, the headache scores significantly decreased in all three groups (all P<0.01). The difference in headache score between the LF-EA and HF-EA groups was not statistically significant (P>0.05), while the score was significantly lower in the VF-EA group than in the LF-EA and HF-EA groups (both P<0.01). Conclusion: VF-EA (2 Hz/100 Hz), compared with LF-EA (2 Hz) and HF-EA (100 Hz), shows superior clinical efficacy in treating migraine.